Get started
Author

Solange Cesar Cavalcante

Observed names: Cavalcante, Solange Cesar, S C Cavalcante, S Cavalcante, S Cesar Cavalcante, S. C. Cavalcante, S. Cavalcante, S.C. Cavalcante, Solange C Cavalcante, Solange C. Cavalcante, Solange Cavalcante, Solange Cesar Cavalcante2,6
Observed institutions: Universidade Federal do Rio de Janeiro, Johns Hopkins University, Vanderbilt University, Fundação de Medicina Tropical, Baltimore City Health Department, Hospital Universitário Clementino Fraga Filho, Instituto Evandro Chagas, Secretaria Municipal de Saúde, Secretaria de Estado de Saúde do Rio de Janeiro, Instituto Nacional de Infectologia Evandro Chagas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz
ORCID: 0000-0002-4154-7016
Observed ORCID: 0000-0002-4154-7016
OpenAlex ID: A5008062120
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
2015 · Haileyesus Getahun, Alberto Matteelli, et al. · European Respiratory Journal · 619
PDF
The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil
2007 · Jonathan E Golub, Valeria Saraceni, et al. · AIDS · 310
III Diretrizes para Tuberculose da Sociedade Brasileira de Pneumologia e Tisiologia
2009 · Marcus Barreto Conde, Fernando Augusto Fiuza de Melo, et al. · Jornal Brasileiro de Pneumologia · 251
PDF
Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection
2015 · Molebogeng X Rangaka, Solange C Cavalcante, et al. · The Lancet · 225
PDF
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
2020 · Adam Penn-Nicholson, Stanley Kimbung Mbandi, et al. · Scientific Reports · 190
PDF
Impact of Replacing Smear Microscopy with Xpert MTB/RIF for Diagnosing Tuberculosis in Brazil: A Stepped-Wedge Cluster-Randomized Trial
2014 · Betina Durovni, Valeria Saraceni, et al. · PLoS Medicine · 143
PDF
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users
2001 · Richard E Chaisson, Grace Link Barnes, et al. · The American Journal of Medicine · 109
Long-term Protection From Isoniazid Preventive Therapy for Tuberculosis in HIV-Infected Patients in a Medium-Burden Tuberculosis Setting: The TB/HIV in Rio (THRio) Study
2014 · J. E. Golub, S. Cohn, et al. · Clinical Infectious Diseases · 106
PDF
Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial
2013 · Betina Durovni, Valeria Saraceni, et al. · The Lancet Infectious Diseases · 106
Cost-Effectiveness of Directly Observed Versus Self-Administered Therapy for Tuberculosis
1996 · R D Moore, C P Chaulk, et al. · American Journal of Respiratory and Critical Care Medicine · 101
Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention
2007 · Lawrence H. Moulton, Jonathan E. Golub, et al. · Clinical Trials · 83
Validation of a Hierarchical Deterministic Record-Linkage Algorithm Using Data From 2 Different Cohorts of Human Immunodeficiency Virus-Infected Persons and Mortality Databases in Brazil
2008 · A. G. Pacheco, V. Saraceni, et al. · American Journal of Epidemiology · 76
PDF
The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) Study
2010 · Betina Durovni, Solange C Cavalcante, et al. · AIDS · 66
Impact and Cost-Effectiveness of Culture for Diagnosis of Tuberculosis in HIV-Infected Brazilian Adults
2008 · David W. Dowdy, Maria C. Lourenço, et al. · PLoS ONE · 56
PDF
Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil
2014 · Betina Durovni, Valeria Saraceni, et al. · Bulletin of the World Health Organization · 53
PDF
Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil.
2008 · V Saraceni, B S King, et al. · PubMed · 50
Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil.
2010 · S C Cavalcante, B Durovni, et al. · PubMed · 47
The impact of the Brazilian Family Health Strategy and the conditional cash transfer on tuberculosis treatment outcomes in Rio de Janeiro: an individual-level analysis of secondary data
2017 · Betina Durovni, Valeria Saraceni, et al. · Journal of Public Health · 46
PDF
Controlled trial of active tuberculosis case finding in a Brazilian favela.
2010 · A C Miller, J E Golub, et al. · PubMed · 44
Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil
2020 · María B. Arriaga, Gustavo Amorim, et al. · International Journal of Infectious Diseases · 43
PDF
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis
2016 · Marcus B. Conde, Fernanda C. Q. Mello, et al. · PLoS ONE · 36
PDF
Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.
2007 · S C Cavalcante, E C C Soares, et al. · PubMed · 33
Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome
2022 · Felipe Ridolfi, Lauren Peetluk, et al. · Clinical Infectious Diseases · 32
PDF
Cutaneous tuberculosis in Rio de Janeiro, Brazil: description of a series of 75 cases
2019 · Danielle Mann, Flavia M. Sant’Anna, et al. · International Journal of Dermatology · 30
The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study
2021 · María B Arriaga, Mariana Araújo-Pereira, et al. · The Journal of Infectious Diseases · 28
PDF
Works count: 78
Citation count: 3,377
H-index: 26
I10-index: 48
Year
Topic
Type